LQDA
Liquidia Corporation
NASDAQ · USHealthcareBiotechnology
$77.08-3.58%
Price as of Jul 20, 2026
LQDA valuation
Liquidia Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 42.62x
- P/E 2026E
- 39.37x
- P/E 2027E
- 28.43x
- P/E 2028E
- 19.96x
- P/S forward
- 21.48x
Trailing multiples
- P/E TTM
- 322.38x
- PEG TTM
- 0.50x
- Price / book
- 63.13x
- Price / sales
- 23.80x
- Price / cash flow
- 142.85x
Enterprise value
- Enterprise value
- $6.8B
- EV / sales
- 23.66x
- EV / EBITDA
- 126.71x
- EV / EBIT
- 149.64x
- Market cap
- $6.9B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.